Overview

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Status:
RECRUITING
Trial end date:
2026-04-30
Target enrollment:
Participant gender:
Summary
A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.
Phase:
PHASE2
Details
Lead Sponsor:
VIVUS LLC
Treatments:
Carmustine